PAEDIATRIC PALLIATIVE CARE GUIDELINES
This document was written in January 2016. Whilst every effort has been made to ensure all information is accurate it remains the responsibility of the prescriber to check this information against the most current available before administering any of the drugs in this document.
It is important to note that the doses of the same medication may vary for different indications and this document should be consulted by symptom section rather than drug name.
Due to limitations of space, information regarding all side-effects and interactions for each drug is not included; further information regarding this should be sought from more detailed texts such as APPM Master Formulary and the British National Formulary for Children.
Many drugs used in the palliative care setting are used for indications or by routes not licensed by the manufacturer, and some information regarding this is included in this document.
In the U.K. unlicensed use is permitted at the discretion of the prescriber, and is the prescriber’s responsibility.
Copyright © 2013 - 2018 Satbir Singh Jassal, Anna Karenia Anderson, Jo Griffiths, Charlotte Mellor, Richard Hain, Victoria Lidstone